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Emerging data suggest that microRNAs (miRNAs) are instrumental in a variety of stress 
responses in addition to their more recognized role in development. Surprisingly, miRNAs, 
which normally suppress expression of target transcripts, may become activators of 
expression during stress. This might be partially explained by new interactions of miRNA/
Argonaute complexes with RNA-binding proteins that relocate from different subcellular 
compartments during stress.microRNAs and Stress
Cells frequently encounter stresses, 
such as a temporary reduction in 
energy or oxygen, a salt imbalance, 
or exposure to UV irradiation. Fur-
thermore, cancer cells are often 
exposed to stress, such as hypoxia 
and nutrient deprivation, especially in 
the poorly angiogenic core of a solid 
tumor. A class of ?22 nucleotide non-
coding RNAs called microRNAs (miR-
NAs) recently have been implicated in 
cellular responses to oxidative stress 
(Kulshreshtha et al., 2007; Leung et 
al., 2006; Marsit et al., 2006), nutri-
ent deprivation (Bhattacharyya et al., 
2006; Vasudevan and Steitz, 2007), 
cardiac pressure overload (van Rooij 
et al., 2007), DNA damage, and onco-
genic stress (Brommer et al., 2007; 
Chang et al., 2007; He et al., 2007; 
Raver-Shapira et al., 2007; Tarasov et 
al., 2007). Genetic knockout of spe-
cific miRNAs renders the mutant ani-
mals incapable of coping with these 
stresses (van Rooij et al., 2007; Xu et 
al., 2003).
In response to stress, cells adapt 
by altering their gene expression 
programs. This can be achieved 
transcriptionally by upregulating a 
subset of messenger RNAs (mRNAs). 
We will discuss here how upregula-
tion of transcripts encoding miRNAs 
may coregulate a set of related genes 
due to the ability of these miRNAs to 
bind to multiple targets (?350 miRNA 
genes are thought to regulate over 
25% of all genes in mammalian cells) 
(reviewed in Jackson and Standart, 
2007; Nilsen, 2007). Alternatively, such adaptation can be effected 
immediately by regulating the exist-
ing pool of mRNAs without any de 
novo synthesis, that is, by selectively 
translating certain mRNAs while halt-
ing translation of the rest (reviewed 
in Holcik and Sonenberg, 2005). The 
translatability and stability of specific 
mRNAs during stress and post-stress 
depend on specific signals encoded 
in their transcripts. Given that miR-
NAs can also modulate the translation 
and/or stability of multiple targeted 
transcripts, we suggest that miRNAs 
play an important regulatory role in 
coping with a spectrum of stresses.
Transcription of miRNAs and 
Coregulation of Related Genes
Nearly all animal miRNAs regulate 
their target mRNAs by binding to their 
3′ UTRs with partial complementarity 
(reviewed in Jackson and Standart, 
2007; Nilsen, 2007), where the critical 
base pairing is between the 2nd and 
8th nucleotide at the 5′ end. Thus, a 
single miRNA recognizes multiple tar-
gets. More importantly, miRNAs coor-
dinately regulate target genes encod-
ing proteins with related functions; 
for example, liver-specific miR-122 
can regulate multiple genes involved 
in cholesterol and fatty acid metabo-
lism (Esau et al., 2006). Potentially, by 
upregulating a single miRNA, cells 
could specifically modify the expres-
sion of multiple target mRNAs in 
response to an environmental stress. 
Indeed, upon DNA damage or onco-
genic stress, the tumor suppressor 
protein p53 activates the transcription Cell 130, of miR-34a, which in turn regulates 
an expression program of cell-cycle 
and DNA-damage response genes to 
prevent inappropriate cell prolifera-
tion (Brommer et al., 2007; Chang et 
al., 2007; He et al., 2007; Raver-Sha-
pira et al., 2007; Tarasov et al., 2007). 
By the same token, the transcription 
factor HIFα induces the expression 
of a select few miRNAs to enhance 
survival of neoplastic cells in hypoxic 
microenvironments (Kulshreshtha et 
al., 2007). In fact, this stress-induced 
upregulation of miRNAs seems to be 
universally observed. For example, 
depriving plants of nutrients such as 
sulfate and phosphate results in the 
upregulation of expression of miR-
395 and miR-399, respectively, which 
coordinately repress the expression 
of their inorganic ion transporters 
and assimilation enzymes (Chiou et 
al., 2006; Jones-Rhoades and Bartel, 
2004; reviewed in Sunkar et al., 2007). 
Therefore, analogous to prokaryotic 
operons or eukaryotic transcription 
factors that regulate a common set 
of cellular genes, a single miRNA 
has the potential to regulate multiple 
functionally related mRNAs posttran-
scriptionally in response to stress.
Mode of miRNA Regulation 
Changes upon Stress
Not all miRNA expression levels 
change upon stress; for example, 
expression of heart-specific miR-208 
remains unchanged even though it 
plays an indispensable role in remod-
eling the overloaded heart to aug-
ment cardiac output (van Rooij et al., August 24, 2007 ©2007 Elsevier Inc. 581
Figure 1. Argonautes, miRNAs, and Stress
(A) Argonaute proteins become localized to stress granules (SGs) upon exposure of the cell to a variety of stresses, and the localization is dependent 
on miRNAs.
(B and C) Argonaute associates with other RNA-binding proteins and becomes an activator. The absence of Argonaute/miRNA targets from spe-
cific cellular structures during stress might be important for miRNA regulation. For example, a fraction of Argonaute is associated with the fragile X 
protein FXR1 in GW bodies (a variant of P bodies; PBs) in HEK293 cells cultured in serum (B). Upon serum starvation, such structures disassemble 
while Argonaute and FXR1 become associated with polysomes. Similarly, Bhattacharyya et al. (2006) have shown that the mRNA for cationic amino 
acid transporter (CAT-1), which is a target of miR-122, is present in PBs of Huh7 cells, but the signal at PBs becomes undetectable when cells are 
starved (C). The absence of signals at PBs requires not only miR-122 but also the RNA-binding protein HuR, which coincides with the association 
of CAT-1 mRNAs with polysomes. In both cases, it seems that the structural localization of factors is inversely correlated with polysome association 
and hence translation.2007). This suggests that the mode of 
miRNA regulation might change upon 
stress. microRNAs mediate transla-
tional repression or mRNA degrada-
tion through the key binding protein 
Argonaute. Interestingly, one of Argo-
naute’s stably associated partners, 
Hsp90, is stress-sensitive and is 
involved in its stability (Liu et al., 2005; 
Tahbaz et al., 2001), although whether 
this association changes upon stress 
still needs to be investigated. Alter-
natively, these proteins involved in 
miRNA regulation could be modified 
posttranslationally in a stress-spe-
cific manner. This has been observed 
with other key regulators of gene 
expression, such as the transcrip-
tion factor HIFα, the proline hydrox-
ylation of which is dependent on the 
level of intracellular oxygen (reviewed 
in Kaelin, 2005). Here, we mention 
two recently discovered aspects of 
Argonaute that are changed upon 
stress: the accessibility and adja-
cent arrangement at miRNA-binding 
sites (Figure 1). We have found that all 
Argonaute family members (Ago1–4) 
are relocated within the cell upon 
stress (Figure 1A) (Leung et al., 2006). 
The association of Argonaute with 
other RNA-binding proteins recently 
has been shown to switch a normally 
repressive miRNA into an activator 582 Cell 130, August 24, 2007 ©2007 Elof its targets when cells are starved 
of serum or amino acids (Figures 1B 
and 1C) (Bhattacharyya et al., 2006; 
Vasudevan and Steitz, 2007).
Accessibility
The cytoplasm is where most mature 
miRNAs become localized and then 
base pair with their target transcripts 
to inhibit translation or induce mRNA 
degradation. Although the majority 
of Argonautes and miRNAs are dis-
tributed diffusely in the cytoplasm, a 
fraction become localized in specific 
cellular structures (reviewed in Leung 
and Sharp, 2006; Nilsen, 2007). 
These structures potentially con-
tain local concentrations of factors 
that are readily accessible to miRNA 
complexes involved in regulation. In 
unstressed cells, Argonaute and miR-
NAs localize to the diffuse cytoplasm 
and in small part to processing bod-
ies (PBs or their variant GW bodies). 
However, upon exposure to stress 
stimuli such as oxidative stress, 
Argonaute and miRNAs additionally 
become localized to newly assembled 
structures known as stress granules 
(SGs) (Leung et al., 2006).
SGs are sites where poly(A)+ 
mRNAs bound by stalled 40S ribo-
somes accumulate when translation 
initiation is inhibited during hypogly-
cemia, viral infection, salt stress, UV sevier Inc.irradiation, or hypoxia (Anderson and 
Kedersha, 2006). SG assembly, usu-
ally initiated by the phosphorylation 
of translation initiation factor eIF2α, 
takes place when different environ-
mental stresses activate distinct 
eIF2α kinases (e.g., PKR, HRI, PERK, 
and GCN2). Therefore, a variety of 
stress conditions probably trigger 
the localization of Argonautes, miR-
NAs, and their targets to SGs. Impor-
tantly, although SGs might appear 
structurally stable, these structures 
disassemble upon relief of stress 
(Anderson and Kedersha, 2006). Fur-
thermore, factors localized in SGs 
are continually moving back and forth 
between SGs and the cytoplasm (for 
example, 50% of Argonautes in SGs 
are replaced within 20 s) (Leung et al., 
2006). Thus, the assembly of these 
organelles can be rapidly dissolved in 
response to changing environments.
Remarkably, the localization of 
Argonaute to SGs requires the pres-
ence of miRNAs (Leung et al., 2006), 
suggesting that Argonaute enters SGs 
through its association with miRNAs. 
Therefore, the resulting colocalization 
with other components that are also 
recruited to SGs during stress might 
provide new opportunities to modu-
late the properties of miRNA targets. 
For example, mRNA-binding proteins, 
such as TIA-1, TIAR, FXR1, HuR, TTP, 
p54/rck, Staufen, CPEB, and ZBP1, 
are also recruited to SGs under stress 
conditions (reviewed in Anderson and 
Kedersha, 2006). These SG compo-
nents are known to regulate mRNA 
translation and/or turnover under 
both normal and stressed conditions. 
Notably, some of these factors includ-
ing FXR1, HuR, p54/rck, and TTP 
have already been shown to associ-
ate with Argonaute (Bhattacharyya et 
al., 2006; Chu and Rana, 2006; Jing 
et al., 2005; Vasudevan and Steitz, 
2007), although whether this depends 
upon bridging mRNA sequences has 
not been adequately tested. These 
possible new interactions might result 
in a rearrangement of existing Argo-
naute-associated complexes within 
SGs, thereby potentially changing the 
stability or translatability of miRNA 
targets there.
SGs are currently considered to 
be sites for mRNA sorting and mRNP 
remodeling upon exposure of cells 
to stress. This might lead to storage/
silencing of certain mRNAs at SGs, 
while the rest transit to PBs for deg-
radation (Anderson and Kedersha, 
2006). Even though the targeting of 
poly(A)+ mRNAs to SGs is non-spe-
cific, a subset of mRNAs that bind to 
specific SG-localized proteins such 
as ZBP1 are preferentially stabilized 
during stress (Stohr et al., 2006). 
Whether Argonaute/miRNA could 
also potentially affect transcript sta-
bility upon stress exposure remains 
to be determined; it is known to down-
regulate the stability of a subset of its 
targets in unstressed cells (Bagga et 
al., 2005; Lim et al., 2005). The activ-
ity of miRNAs on their mRNA targets 
depends on the relative concentration 
of miRNAs and mRNAs (Doench and 
Sharp, 2004). Thus, if there is a differ-
ential change in the relative concen-
tration of target mRNAs upon stress, 
an existing pool of miRNAs might be 
binding to different sets of targets in a 
short temporal window. More impor-
tantly, the association of miRNAs with 
their targets during stress does not 
necessarily result in repression but 
could also result in activation (Bhat-
tacharyya et al., 2006; Vasudevan 
and Steitz, 2007).Adjacency
Bhattacharyya et al. (2006) and 
Vasudevan and Steitz (2007) dem-
onstrate another feature in modulat-
ing miRNA function during stress: 
the requirement of an occupied 
RNA-binding protein site adjacent 
to the miRNA-binding site in tar-
geted mRNAs. For example, an 
ELAV RNA-binding protein family 
member HuR (Bhattacharyya et al., 
2006) and the fragile X protein FXR1 
(Vasudevan and Steitz, 2007) are 
both required for Argonaute-medi-
ated upregulation; knockdown of 
these components abrogates the 
upregulation. However, the require-
ment of neighboring protein-binding 
sites is not limited to miRNA-medi-
ated upregulation. For example, in 
the worm, one of the founding miRNA 
members, let-7, strictly requires a 27 
nucleotide spacer between two con-
served miRNA-binding sites in the 
3′ UTR of its target transcript lin-41 
for downregulation of this gene (Vella 
et al., 2004). The spacer cannot be 
replaced by other sequences of the 
same length, suggesting that it might 
contain other sites for RNA-binding 
proteins. Genetic data suggest that 
a member of the conserved Puf pro-
tein family—which binds to specific 
RNA regulatory elements in the 3′ 
UTR—is responsible for the repres-
sion of let-7 targets, including lin-41, 
during worm development (Nolde et 
al., 2007). Similarly, Jing et al. (2005) 
reported that miR-16 negatively regu-
lates TNFα, requiring not only that the 
miRNA be bound to Ago2/4 but also 
that an RNA-binding protein tristetra-
prolin (TTP) binds to the neighboring 
AU-rich elements (AREs). These data 
suggest that Argonaute family mem-
bers often interact with other RNA-
binding proteins in order to modulate 
the functions of miRNAs.
So, how do external stimuli change a 
normally repressive miRNA to an acti-
vator? Interestingly, many ARE-bind-
ing proteins, such as TTP and HuR, 
are localized predominantly in the 
nucleus and become redistributed to 
the cytoplasm in response to extracel-
lular stimuli. On the other hand, most 
mature miRNAs and their core bind-
ing Argonaute proteins are found in Cell 130, Athe cytoplasm. Hence, the cytoplasm 
is the common ground where miRNA-
mediated functions can be modulated 
by these RNA-binding proteins. Tar-
gets of miRNAs thus can be regu-
lated by limiting the amount of these 
nucleocytoplasmic shuttling RNA-
binding proteins in the cytoplasm in 
response to certain cellular states. For 
instance, transport of HuR to the cyto-
plasm is repressed by AMP-activated 
kinase. The activity is regulated by the 
intracellular AMP:ATP ratio. Cellular 
stresses that decrease this ratio, such 
as UV irradiation, result in elevated 
transport of HuR to the cytoplasm, 
whereas simple ATP depletion caused 
by hypoglycemia and loss of growth 
factors does not (Wang et al., 2002). 
Alternatively, those RNA-binding pro-
teins that are already localized in the 
cytoplasm can be activated by post-
translational modifications in a signal-
dependent manner. For example, TTP 
requires phosphorylation of at least 
one serine residue in its C terminus 
to be able to bind to the scaffolding 
protein 14-3-3, which facilitates its 
cytoplasmic localization (Johnson et 
al., 2002; Stoecklin et al., 2004). Addi-
tionally, miRNA, Argonaute, and a 
subset of these RNA-binding proteins 
can also localize to specific struc-
tures like SGs upon certain stresses, 
thereby possibly creating a special-
ized locale for distinct functions of 
miRNAs. It is noteworthy that SGs 
also contain proteins that regulate 
diverse cell signaling pathways (such 
as TRAF2; roquin; plakophilin 1 and 
3; and DISC-1, Disrupted-in-Schizo-
phrenia-1) (reviewed in Anderson and 
Kedersha, 2006). Such combinatorial 
requirements for both miRNAs and 
RNA-binding proteins would provide 
a mechanism for changing the tran-
scriptome and proteome on a global 
scale yet with specificity—miRNA-
binding sites would provide the target 
specificity and other 3′ UTR-binding 
sites could sense the cellular state 
by coupling with signaling pathways. 
Resembling a coincidence detector, 
miRNA targets would be upregulated 
differentially only when both compo-
nents are bound at the 3′ UTR (Bhat-
tacharyya et al., 2006; Vasudevan and 
Steitz, 2007).ugust 24, 2007 ©2007 Elsevier Inc. 583
microRNAs: Gatekeepers of Gene 
Expression
In the event of insufficient miRNAs, 
their targets would become mis-
regulated and the organism might 
be less able to cope with chang-
ing environments. For example, 
absence of miR-14 in Drosophila 
results in a greater sensitivity of the 
fly to salt imbalance (Xu et al., 2003); 
meanwhile, heart-specific miR-208 
is required in mice for remodeling 
their hearts during cardiac stress 
(van Rooij et al., 2007). These phe-
notypes might be explained by the 
lack of one or more master regula-
tors for particular stresses due to 
the absence of specific miRNAs. 
Alternatively, these phenotypes 
could be a cumulative effect of sub-
tle misregulation of miRNA targets 
or of a coordinated gene expression 
program (if the targets are of related 
function). Several validated endog-
enous miRNA targets have been 
shown to be repressed at relatively 
moderate levels (?1- to 2-fold). Such 
examples include the transcriptional 
coactivator THRAP1 regulated by 
miR-208 (van Rooij et al., 2007) 
and the signaling protein Ras regu-
lated by let-7 (Chu and Rana, 2006; 
Johnson et al., 2005). Therefore, the 
regulatory effect of miRNAs might 
not be manifested physiologically 
under normal conditions but might 
play an indispensable role enabling 
the organism to cope with stress-
ful environmental changes. Such a 
possibility is demonstrated by the 
absence of an apparent phenotype 
in adult mice lacking miR-208 until 
they are stressed (van Rooij et al., 
2007).
microRNAs have several proper-
ties that make them an ideal candi-
date for safeguarding the organism 
during stress. First, miRNAs strate-
gically regulate the final steps in the 
translation of genes into their prod-
ucts: that is, they control the stabil-
ity and translation of numerous tar-
get mRNAs that are already present 
prior to stress. Thus, when stress 
conditions cease, the cell could be 
programmed to commence multiple 
corrective processes immediately 
thus enhancing survival. Second, 584 Cell 130, August 24, 2007 ©2007 ElsmiRNAs can tune gene expression 
up or down, depending on miRNP 
association with other RNA-binding 
proteins. Third, one miRNA can bind 
to multiple transcripts due to its 
relatively low requirement of com-
plementarity, thereby potentially 
allowing switching between targets 
during stress.
Cancer, Stress, and miRNA 
Regulation
Tumor cells experience a variety of 
stresses such as hypoxia, nutrient 
deprivation, and of course exposure 
to irradiation and chemotherapeutic 
compounds during treatment of the 
patient. If miRNA regulation is a criti-
cal aspect of the stress response, then 
knowledge of its molecular aspects 
might identify targets for drugs to 
enhance the effectiveness of cancer 
treatments. This is not too farfetched 
given that similar logic has identified 
the heat shock protein Hsp90 as a 
contemporary target for future oncol-
ogy drugs (Vastag, 2006). Relative 
to their normal counterparts, cancer 
cells may exhibit unique alterations in 
pathways controlled by miRNAs that 
could be exploited to specifically kill 
tumors.
Conclusion
The conservation of target sites in the 
3′ UTR of mRNAs strongly indicates 
that miRNAs regulate expression of a 
sizeable fraction of all animal genes 
(e.g., > 25% in mammals). Many of 
these sites could be critical for con-
trolling responses to stress but may 
not be essential under normal condi-
tions. During stress, binding of miR-
NAs could activate gene expression 
in contrast to their ostensibly default 
silencing mode. Future studies should 
more clearly elucidate the importance 
of miRNAs in regulating gene expres-
sion and promoting survival during 
times of stress.
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